These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. A sustained increase of plasma fibrinogen in sudden sensorineural hearing loss predicts worse outcome independently. Park YA; Kong TH; Seo YJ Am J Otolaryngol; 2017; 38(4):484-487. PubMed ID: 28502595 [TBL] [Abstract][Full Text] [Related]
44. Low density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome. Kansai-FGS-Apheresis Treatment (K-FLAT) Study Group. Muso E; Mune M; Fujii Y; Imai E; Ueda N; Hatta K; Imada A; Miki S; Kuwahara T; Takamitsu Y; Takemura T; Tsubakihara Y Kidney Int Suppl; 1999 Jul; 71():S122-5. PubMed ID: 10412754 [TBL] [Abstract][Full Text] [Related]
46. Apheresis technology for prevention and regression of atherosclerosis: an overview. Yamamoto A; Kawaguchi A; Harada-Shiba M; Tsushima M; Kojima S Ther Apher; 1997 Aug; 1(3):233-41. PubMed ID: 10225745 [TBL] [Abstract][Full Text] [Related]
47. Single LDL apheresis improves serum remnant-like particle-cholesterol, C-reactive protein, and malondialdehyde-modified-low-density lipoprotein concentrations in Japanese hypercholesterolemic subjects. Kobayashi J; Katsube S; Shimoda M; Furuhashi K; Kitano S; Masuda M; Maruyama T; Shinomiya M Clin Chim Acta; 2002 Jul; 321(1-2):107-12. PubMed ID: 12031599 [TBL] [Abstract][Full Text] [Related]
48. The first results demonstrating efficiency and safety of a double-column whole blood method of LDL-apheresis. Hequet O; Le QH; Rigal D; Mekhloufi F; Jaeger S; Sassolas A; Groisne L; Moulin P Transfus Apher Sci; 2010 Feb; 42(1):3-10. PubMed ID: 19932056 [TBL] [Abstract][Full Text] [Related]
49. Low density lipoprotein apheresis in treatment of hyperlipidemia: experience with four different technologies. Bambauer R; Schiel R; Latza R Ther Apher; 2000 Jun; 4(3):213-7. PubMed ID: 10910023 [TBL] [Abstract][Full Text] [Related]
51. Effect of different LDL-apheresis methods on parameters involved in atherosclerosis. Hershcovici T; Schechner V; Orlin J; Harell D; Beigel Y J Clin Apher; 2004; 19(2):90-7. PubMed ID: 15274202 [TBL] [Abstract][Full Text] [Related]
52. Potential Benefits of Combination Therapy as Primary Treatment for Sudden Sensorineural Hearing Loss. Lee JB; Choi SJ Otolaryngol Head Neck Surg; 2016 Feb; 154(2):328-34. PubMed ID: 26556463 [TBL] [Abstract][Full Text] [Related]
53. Intraindividual comparison of two extracorporeal LDL apheresis methods: lipidfiltration and HELP. Julius U; Metzler W; Pietzsch J; Fassbender T; Klingel R Int J Artif Organs; 2002 Dec; 25(12):1180-8. PubMed ID: 12518963 [TBL] [Abstract][Full Text] [Related]
54. Hyperbaric oxygen as salvage treatment for idiopathic sudden sensorineural hearing loss. Psillas G; Ouzounidou S; Stefanidou S; Kotsiou M; Giaglis GD; Vital I; Tsalighopoulos M; Markou K B-ENT; 2015; 11(1):39-44. PubMed ID: 26513946 [TBL] [Abstract][Full Text] [Related]
55. The Short- and Long-Term Outcome of Intratympanic Steroid Therapy as a Salvage Treatment for Acute Low-Tone Sensorineural Hearing Loss without Episodes of Vertigo. Morita S; Nakamaru Y; Fujiwara K; Iizuka K; Masuya M; Homma A; Fukuda A; Fukuda S Audiol Neurootol; 2016; 21(3):132-40. PubMed ID: 27077389 [TBL] [Abstract][Full Text] [Related]
56. The effects of three different LDL-apheresis methods on the plasma concentrations of E-selectin, VCAM-1, and ICAM-1. Empen K; Otto C; Brödl UC; Parhofer KG J Clin Apher; 2002; 17(1):38-43. PubMed ID: 11948705 [TBL] [Abstract][Full Text] [Related]
57. Intratympanic steroid injection as a salvage treatment for sudden sensorineural hearing loss. Belhassen S; Saliba I J Laryngol Otol; 2014 Dec; 128(12):1044-9. PubMed ID: 25399754 [TBL] [Abstract][Full Text] [Related]
58. Short-term and long-term effects of low-density lipoprotein (LDL) apheresis on restenosis after percutaneous transluminal coronary angioplasty (PTCA): is lowering Lp(a) by LDL apheresis effective on restenosis after PTCA? Kanemitsu S; Takekoshi N; Matsui S; Tsugawa H; Ohkubo S; Kitayama M; Matsuda T; Senma J; Masuyama K; Yamagata T; Murakami E Ther Apher; 1998 Feb; 2(1):65-70. PubMed ID: 10227791 [TBL] [Abstract][Full Text] [Related]
59. Comparison of Two Different Treatment Protocols Using Systemic and Intratympanic Steroids with and without Hyperbaric Oxygen Therapy in Patients with Severe to Profound Idiopathic Sudden Sensorineural Hearing Loss: A Randomized Controlled Trial. Cho I; Lee HM; Choi SW; Kong SK; Lee IW; Goh EK; Oh SJ Audiol Neurootol; 2018; 23(4):199-207. PubMed ID: 30380530 [TBL] [Abstract][Full Text] [Related]
60. Efficacy comparison of oral steroid, intratympanic steroid, hyperbaric oxygen and oral steroid + hyperbaric oxygen treatments in idiopathic sudden sensorineural hearing loss cases. Alimoglu Y; Inci E; Edizer DT; Ozdilek A; Aslan M Eur Arch Otorhinolaryngol; 2011 Dec; 268(12):1735-41. PubMed ID: 21431435 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]